Treatment for temporal arteritis Temporal arteritis is treated with steroid medicine, usually prednisolone. Treatment will be started before temporal arteritis is confirmed because of the risk of vision loss if it’s not dealt with quickly.

Most patients with giant cell arteritis require at least two years of corticosteroid therapy.

It is generally agreed that most patients with suspected GCA should be started on oral prednisone 40-60 mg/day, with a temporal artery biopsy performed within 1 week. Prednisone doses of 80-100 mg/day have been suggested for patients with visual or neurologic symptoms of GCA.

Treatment and Course of Giant Cell Arteritis GCA requires treatment with prednisone, a type of corticosteroid. Typically, treatment begins with 40–60 mg of prednisone, taken by mouth each day. Most patients improve rapidly and dramatically on this dose, with improvement of most symptoms in 1–3 days.

Temporal arteritis cannot heal on its own and requires immediate medical treatment.

Retrospective but impressive data from Nesher and colleagues support the use of low-dose aspirin (81 mg) in patients with GCA for prevention of visual loss and stroke. This therapy should be considered for patients diagnosed with GCA who do not have contraindications to its use.

Panafcortelone contains prednisolone as the active ingredient. Prednisolone belongs to a group of medicines called corticosteroids which are a synthetic version of a naturally occurring body hormone called cortisol. Panafcortelone works by entering inflammatory cells and blocking the inflammatory reaction.

It is used to treat conditions such as arthritis, blood problems, immune system disorders, skin and eye conditions, breathing problems, cancer, and severe allergies. It decreases your immune system’s response to various diseases to reduce symptoms such as pain, swelling and allergic-type reactions.